BRD9 is a non-BET bromodomain-containing protein that maintains and facilitates oncogenic transcription directly by recognizing the acetylated lysine on post-translationally modified histone proteins, contributing to cancer cell proliferation and survival29,30. This evidence concerns the gene H2BC12L and cancer.